Jordan Smith, MD
Orthopaedic Surgery · Tucson, AZNPI 1306906144
Payments from drug & device makers
Across 37 payments — averaging $193.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$4K
- Smith+Nephew$2K
- Zimmer Biomet$398
- Kls-martin L.p.$211
- Novo Nordisk$113
- Johnson & Johnson$110
- plus $205 from 7 others
What the payments were for
- Consulting fees$4,09457%
- Travel & lodging$1,62123%
- Food & beverage$1,22417%
- Education$2133%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 3 | $4,258 |
| Smith+Nephew | 14 | $1,856 |
| Zimmer Biomet | 4 | $398 |
| Kls-martin L.p. | 2 | $211 |
| Novo Nordisk | 1 | $113 |
| Johnson & Johnson | 4 | $110 |
| Stryker | 3 | $56 |
| Pacira Pharmaceuticals Incorporated | 1 | $39 |
| Masimo Corporation | 1 | $30 |
| Lifenet Health | 1 | $24 |
| Pfizer | 1 | $24 |
| Baudax Bio Inc. | 1 | $17 |
| Sun Pharmaceutical Industries Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACTIS$4,199
- Kincise$4,199
- Velys$4,199
- POLARSTEM$1,516
- REDAPT$586
- RI.HIP NAVIGATION$586
- Avenir$213
- REAL INTELLIGENCE$150
- CMF & Thoracic Product Portfolio$124
- Saxenda$113
How this compares
$7,151 in reported general payments places this provider in the 55th percentile of 377 orthopaedic surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 129 | $4,421 |
| Gabapentin | 56 | $833 |
| Oxycodone Hcl | 110 | $611 |
| Dexamethasone | 135 | $555 |
| Ondansetron Hcl | 123 | $533 |
| Doxycycline Hyclate | 35 | $291 |
| Cephalexin | 101 | $191 |
| Tramadol Hcl | 21 | $54 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Tucson
- Leonard LattTucson$237K
- Rex CooleyTucson$47K
- Nathan ShermanTucson$40K
- David FalgoutTucson$40K
- Joseph GimbelPhoenix$19.4M
- Evan LedermanPhoenix$13.4M
- James ChowPhoenix$6.2M
- Michael McKeePhoenix$3.4M
- Henry ClarkePhoenix$1.9M
- Samuel HarmsenPhoenix$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.